Literature DB >> 15126082

Increased apoptosis is specific for acute rejection in rat small bowel transplant.

Thomas M Fishbein1, Jianhua Liu, Liqing Wang, Yansui Li, Peter Boros.   

Abstract

Apoptosis has been associated with several events in solid organ transplantation, including ischemia/reperfusion (IR) injury and acute rejection. To determine whether apoptosis-profiles may distinguish these two conditions, we analyzed apoptosis rates in a rat orthotopic small bowel transplant (SBT) model. SBT was performed in Lewis rats with either freshly harvested or preserved (4 h, in UW at 4 degrees C) syngeneic and allogeneic (Brown-Norway) grafts. Bowel samples were collected 2 h after reperfusion and on small bowel transplant postoperative days (POD) 1, 4, and 7. Apoptosis was detected by measuring levels of histone-associated DNA fragments and caspase 3 expression, and by determining apoptotic body counts. All markers measured 2 h after reperfusion increased profoundly in association with preservation. After a significant decrease on POD 1, apoptosis rates rose again between POD 4 and 7 only in allogeneic grafts. This distinct second increase in apoptosis may be an early and specific sign of acute rejection.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15126082     DOI: 10.1016/j.jss.2003.12.028

Source DB:  PubMed          Journal:  J Surg Res        ISSN: 0022-4804            Impact factor:   2.192


  2 in total

1.  Reduction of acute rejection by bone marrow mesenchymal stem cells during rat small bowel transplantation.

Authors:  Yang Yang; Hong-Li Song; Wen Zhang; Ben-Juan Wu; Nan-Nan Fu; Wei-Ping Zheng; Chong Dong; Chong Don; Zhong-Yang Shen
Journal:  PLoS One       Date:  2014-12-15       Impact factor: 3.240

2.  Heme oxygenase-1-transduced bone marrow mesenchymal stem cells in reducing acute rejection and improving small bowel transplantation outcomes in rats.

Authors:  Yang Yang; Hong Li Song; Wen Zhang; Ben Juan Wu; Nan Nan Fu; Chong Dong; Zhong Yang Shen
Journal:  Stem Cell Res Ther       Date:  2016-11-20       Impact factor: 6.832

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.